The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age. (Q36903288)
Jump to navigation
Jump to search
scientific article published on 26 February 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age. |
scientific article published on 26 February 2013 |
Statements
1 reference
The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age. (English)
1 reference
Marco Gattorno
1 reference
Alberto Martini
1 reference
Roberta Caorsi
1 reference
Antonella Insalaco
1 reference
Loredana Lepore
1 reference
Francesco Zulian
1 reference
Maria Alessio
1 reference
Achille Stabile
1 reference
Martina Finetti
1 reference
Antonella Battagliese
1 reference
Giorgia Martini
1 reference
Chiara Bibalo
1 reference
1 reference
1 reference
1 reference